| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6126045 | Transplant Immunology | 2013 | 5 Pages |
Abstract
Overall 7% of the lung transplant recipients with IA appear to develop an IRS-like entity. Clinically assessable factors can identify patients at risk for post-transplant IA-associated IRS. Deaths due to chronic rejection were significantly higher in patients with IRS than those without IRS.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Nina Singh, Jose F. Suarez, Robin Avery, Cornelia Lass-Flörl, Christian Geltner, Alessandro C. Pasqualotto, G. Marshall Lyon, Michelle Barron, Shahid Husain, Marilyn M. Wagener, Jose G. Montoya,